377 related articles for article (PubMed ID: 15737316)
1. [Pseudomyxoma peritonei: new concept and new therapeutic approach].
Loungnarath R; Causeret S; Brigand C; Gilly FN; Glehen O
Ann Chir; 2005 Feb; 130(2):63-9. PubMed ID: 15737316
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.
Loungnarath R; Causeret S; Bossard N; Faheez M; Sayag-Beaujard AC; Brigand C; Gilly F; Glehen O
Dis Colon Rectum; 2005 Jul; 48(7):1372-9. PubMed ID: 15909071
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
Sugarbaker PH
Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
[TBL] [Abstract][Full Text] [Related]
4. [Pseudomyxoma peritonei; a rare tumour that can be treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Smeenk RM; Verwaal VJ; Zoetmulder FA
Ned Tijdschr Geneeskd; 2007 Feb; 151(7):418-23. PubMed ID: 17343142
[TBL] [Abstract][Full Text] [Related]
5. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy.
Elias D; Gilly F; Quenet F; Bereder JM; Sidéris L; Mansvelt B; Lorimier G; Glehen O;
Eur J Surg Oncol; 2010 May; 36(5):456-62. PubMed ID: 20227231
[TBL] [Abstract][Full Text] [Related]
6. Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study.
Jess P; Iversen LH; Nielsen MB; Hansen F; Laurberg S; Rasmussen PC
Dis Colon Rectum; 2008 Jun; 51(6):868-74. PubMed ID: 18297361
[TBL] [Abstract][Full Text] [Related]
7. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
8. [Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy].
Elias D; Laurent S; Antoun S; Duvillard P; Ducreux M; Pocard M; Lasser P
Gastroenterol Clin Biol; 2003 Apr; 27(4):407-12. PubMed ID: 12759682
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and therapeutic considerations in pseudomyxoma peritonei].
Constantinoiu S; Chiru F; Mateş IN; Pop D; Cochior D; Bârlă R; Dinu D; Predescu D; Predescu V
Chirurgia (Bucur); 1998; 93(1):27-37. PubMed ID: 9567459
[TBL] [Abstract][Full Text] [Related]
10. [Pseudomyxoma peritonei].
Andreassen G
Tidsskr Nor Laegeforen; 1995 Sep; 115(22):2783. PubMed ID: 7570495
[TBL] [Abstract][Full Text] [Related]
11. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal chemohyperthermia: rationale, technique, indications, and results.
Elias DM; Ouellet JF
Surg Oncol Clin N Am; 2001 Oct; 10(4):915-33, xi. PubMed ID: 11641098
[TBL] [Abstract][Full Text] [Related]
13. Cytoreduction including total gastrectomy for pseudomyxoma peritonei.
Sugarbaker PH
Br J Surg; 2002 Feb; 89(2):208-12. PubMed ID: 11856136
[TBL] [Abstract][Full Text] [Related]
14. Pseudomyxoma peritonei.
Witham G
Nurs Times; 2003 Sep 30-Oct 6; 99(39):30-2. PubMed ID: 14562659
[TBL] [Abstract][Full Text] [Related]
15. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Smeenk RM; Verwaal VJ; Antonini N; Zoetmulder FA
Ann Surg; 2007 Jan; 245(1):104-9. PubMed ID: 17197972
[TBL] [Abstract][Full Text] [Related]
16. [Peritoneal tumor pathology - case no. 1: pseudomyxoma peritonei].
Dartigues P
Ann Pathol; 2015 Aug; 35(4):311-20. PubMed ID: 26210688
[No Abstract] [Full Text] [Related]
17. Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: a study of timing and the impact of malignant dedifferentiation.
Chua TC; Al-Zahrani A; Saxena A; Liauw W; Zhao J; Morris DL
J Am Coll Surg; 2010 Oct; 211(4):526-35. PubMed ID: 20729102
[TBL] [Abstract][Full Text] [Related]
18. [Two cases of pseudomyxoma peritonei that responded to intraperitoneal administrations of a combined CDDP, 5-FU and MMC therapy].
Sasaki A; Terashima M; Okamoto K; Ikeda K; Takagane A; Takiyama I; Kuboi M; Sasaki N; Saito K
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1571-4. PubMed ID: 8854808
[TBL] [Abstract][Full Text] [Related]
19. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Baratti D; Kusamura S; Nonaka D; Cabras AD; Laterza B; Deraco M
Ann Surg; 2009 Feb; 249(2):243-9. PubMed ID: 19212177
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei.
Hsu KH; Chou CY; Chang YC
Hepatogastroenterology; 2007; 54(73):47-52. PubMed ID: 17419229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
